One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
  • Report Library
  • Who Trust Us
  • inquiry@market.us
  • +1 718 618 4351 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
  • Report Library
  • Who Trust Us
Home » Real World Evidence (RWE) Solutions Market
Real World Evidence (RWE) Solutions Market
Real World Evidence (RWE) Solutions Market
Published date: Feb 2022 •Formats:
Request Sample Schedule a Call
  • Home » Real World Evidence (RWE) Solutions Market

Global Real World Evidence (RWE) Solutions Market Based on Component: (Services, Data Sets, Clinical Setting Data) Based on Therapeutic Area: (Oncology, Cardiovascular, Other Therapeutic Area) Based on End-Users: (Healthcare Providers, Healthcare Payers, Other End Users) by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

  • Published date: Feb 2022
  • Report ID: 83875
  • Number of Pages: 255
  • Format:
  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Sample
  • Real World Evidence (RWE) Solutions Market Overview:

    The global real-world evidence/RWE solutions market is projected to reach a valuation of USD 5,671.07 Mn by 2032 at a CAGR of 13.5%, from USD 1,598.48 Mn in 2022.

    Every day, new devices and devices with new features are launched. The plethora of Real World Evidence (RWE) that has been collected to help us make informed decisions on these devices has become essential.

    real world evidence solutions analysis

    Real-world evidence or RWE is the use of data collected from large groups of patients in real-world settings to support medical decision-making. The “real world” refers to all areas outside a traditional clinical trial setting which includes different patient populations, treatments, and dosing schedules. RWE is increasingly being used as an effective tool to generate evidence for healthcare stakeholders to support treatment decisions.

    With the growing number of patients and limited medical personnel, the cost of healthcare is continually on the rise. In order to stay competitive in this market, healthcare providers must find new ways to keep costs down and work towards more efficient ways of reaching their goals. Real-world evidence solutions help hospitals receive insights on how to improve processes in order to decrease personnel hours spent on routine tasks, which in turn decreases overall costs.

    Global Real World Evidence/RWE Solutions Market Revenue (USD Mn), 2021–2031:

    real world evidence solutions revenue

    Traditional pharmacovigilance tools (such as the Periodic Benefit-Risk Evaluation Report, Periodic Safety Update Report, and Vaccine Adverse Event Reporting System) as well as newer digital tools, such as the FDA Sentinel Initiative, a post-market active safety surveillance system, are used by regulators to monitor the safety of marketed products. RWE is presently being utilized in pre-approved efficacy decisions, and it has the potential to be used more widely in oncology, to treat uncommon diseases, and for pediatric ailments where randomized controlled clinical trials are impractical or unethical to execute.

    Legislators are also understanding the importance of RWE. The United States’ 21st Century Cures Act, passed in December 2016, established public-private partnerships to collect data and increase illness understanding. It also promotes patient-centered medication research and has updated the design and review of clinical studies. Regulators are also expressing a wish to make RWE a significantly bigger part of their operations. This is reflected in the FDA’s efforts to build a single system to monitor the safety of medical products by combining data from electronic medical records, claims data, and registries.

    Similarly, the National Institutes of Health (NIH) established a common fund to develop infrastructure, operational knowledge, and capacity for “pragmatic research,” which integrates electronic health records and other real-world data into large-scale distributed research networks to allow researchers to more easily identify a network of interest and speed-up studies.

    A fundamental difficulty in this sector is the lack of globally acknowledged rules or principles for the design, conduct, analysis, and reporting of RWE. Because of this lack of agreement, RWE is frequently not considered of adequate quality to be included in the body of data used to compare the efficacy of various treatment choices. This reduces the incentive to generate information by lowering the potential value of the information produced. Furthermore, important players are hesitant to adopt RWE as a result of this.

    The healthcare ecosystem is always evolving. Globally, “value” is being scrutinized more closely as healthcare finance players look for innovative ways to deal with the burden of unsustainable costs and low ROI or return on investment. Companies require robust evidence lifecycle management capability to prove value. This has opened the door for an end-to-end strategy to leverage a life sciences organization’s data, evidence, and knowledge assets, breaking down traditional silos and enabling insight-driven decision-making from R&D to product commercialization. Establishing an effective governance plan, using technologies like cloud and self-service analytics, and offering the capacity to combine data sets and comprehend relevant resources for the required analytics are all part of this (and tactical issues around data access and quality).

    Frontage Labs, ICON Plc, and ACM Global Laboratories are currently offering end-to-end RWE and late-phase services including research planning, protocol preparation, clinical study management, and reporting. The increased need for complete evidence services throughout the product lifecycle is likely to give RWE vendors the opportunity to boost their investments through the entire drug development cycle.

    real world evidence solutions company share

    This research report on the global real-world evidence/RWE solutions market includes major company profiles such as:

    • Frontage Labs
    • ICON plc
    • ACM Global Laboratories
    • Cerba Research
    • Sonic Clinical Trials
    • Celerion
    • CIRION BioPharma Research Inc.
    • Clinical Reference Laboratory Inc.
    • Labcorp Drug Development
    • Eurofins Scientific
    • Others

    The Global Real World Evidence/RWE Solutions Market Segmentation is Based on Component, Therapeutic Area, End-User, and Region

    Based on Component

    • Services
    • Data Sets
    • Clinical Setting Data
    • Claims Data
    • Pharmacy Data
    • Patient Powered Data

    Based on Therapeutic Area

    • Oncology
    • Cardiovascular
    • Neurology
    • Immunology
    • Other Therapeutic Area

    Based on End-Users

    • Pharmaceutical and Medical Devices Companies
    • Healthcare Providers
    • Healthcare Payers
    • Other End Users

    Based on Region

    • North America
    • Europe
    • Asia-Pacific
    • South America
    • Middle East & Africa

    For the Real World Evidence Solutions Market research study, the following years have been considered to estimate the market size:

    AttributeReport Details

    Historical Years

    2016-2020

    Base Year

    2021

    Estimated Year

    2022

    Short Term Projection Year

    2028

    Projected Year

    2023

    Long Term Projection Year

    2032

    Report Coverage

    Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.

    Regional Scope

    North America, Europe, Asia-Pacific, South America, Middle East & Africa

    Country Scope

    United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa

    Share
    Tweet
    Share
    Pin
    0 Shares
    Real World Evidence (RWE) Solutions Market
    Real World Evidence (RWE) Solutions Market
    Published date: Feb 2022
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
    • Frontage Labs
    • ICON plc
    • ACM Global Laboratories
    • Cerba Research
    • Sonic Clinical Trials
    • Celerion
    • CIRION BioPharma Research Inc.
    • Clinical Reference Laboratory Inc.
    • Labcorp Drug Development
    • Eurofins Scientific
    • Others
  • settingsSettings

Related Reports

  • Muscle Pain Treatment Market
  • Electrolyte Analysers Market
  • Lower Extremity Prostheses Market
  • Electroporators Market
  • Sample Preparation Market
  • Civil Engineering Market

Our Clients

  • Our Clients
Inquiry Before Buying

Real World Evidence (RWE) Solutions Market
  • 83875
  • Feb 2022
    • ★★★★★
      ★★★★★
    • (79)
  • US $5,999
    US $2,999
  • US $7,999
    US $3,499
  • US $12,999
    US $4,499
Buy Now
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$5,999
$2,999
USD / per unit
save 50%
Multi User
$7,999
$3,499
USD / per unit
save 55%
Corporate User
$12,999
$4,499
USD / per unit
save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 2,999)Buy Now ($ 3,499)Buy Now ($ 4,499)
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
auto undefined
af Afrikaanssq Albanianam Amharicar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbn Bengalibs Bosnianbg Bulgarianca Catalanceb Cebuanony Chichewazh-CN Chinese (Simplified)zh-TW Chinese (Traditional)co Corsicanhr Croatiancs Czechda Danishnl Dutchen Englisheo Esperantoet Estoniantl Filipinofi Finnishfr Frenchfy Frisiangl Galicianka Georgiande Germanel Greekgu Gujaratiht Haitian Creoleha Hausahaw Hawaiianiw Hebrewhi Hindihmn Hmonghu Hungarianis Icelandicig Igboid Indonesianga Irishit Italianja Japanesejw Javanesekn Kannadakk Kazakhkm Khmerko Koreanku Kurdish (Kurmanji)ky Kyrgyzlo Laola Latinlv Latvianlt Lithuanianlb Luxembourgishmk Macedonianmg Malagasyms Malayml Malayalammt Maltesemi Maorimr Marathimn Mongolianmy Myanmar (Burmese)ne Nepalino Norwegianps Pashtofa Persianpl Polishpt Portuguesepa Punjabiro Romanianru Russiansm Samoangd Scottish Gaelicsr Serbianst Sesothosn Shonasd Sindhisi Sinhalask Slovaksl Slovenianso Somalies Spanishsu Sundanesesw Swahilisv Swedishtg Tajikta Tamilte Teluguth Thaitr Turkishuk Ukrainianur Urduuz Uzbekvi Vietnamesecy Welshxh Xhosayi Yiddishyo Yorubazu Zulu
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
  • Report Library

© 2025 Market.Us. All Rights Reserved.